What is Abbiotec?
Abbiotec specializes in supplying a comprehensive suite of research tools essential for scientific discovery within the life sciences sector. Their extensive product catalog includes antibodies, peptides, proteins, and custom synthesis services, catering to a diverse range of applications such as infectious diseases and Alzheimer's research. The company primarily serves researchers and institutions in the biomedical field, aiming to accelerate advancements in proteomics and the development of novel therapeutics. Abbiotec's commitment to innovation empowers scientists in their pursuit of deeper biological understanding.
How much funding has Abbiotec raised?
Abbiotec has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Abbiotec?
With substantial expansion capital secured, Abbiotec is poised for significant growth and operational scaling. The company's strategic positioning at the Series B/C stage suggests a focus on broadening its market reach, enhancing its product development pipeline, and potentially exploring new research areas. This financing is expected to fuel further innovation in its antibody and protein offerings, reinforcing its role as a key supplier to the biomedical research community and facilitating the advancement of therapeutic development.
See full Abbiotec company page
